염증성 장 질환 치료 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00003491
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

시장 개요

염증성 장질환(IBD)은 다음과 같은 용어입니다. 소화관의 만성 염증과 관련된 장애를 설명하는 데 사용됩니다. IBD의 두 가지 유형에는 일반적으로 심한 설사, 복통, 피로 및 체중 감소를 수반하는 궤양성 대장염과 크론병이 있습니다. IBD 치료는 징후와 증상을 유발하는 염증을 줄이는 것입니다. 치료에는 약물요법이나 수술이 포함됩니다. 약물 치료에는 결장의 영향을 받는 부위에 따라 메살라민(Asacol HD, Delzicol 등), 발사라지드(Colazal) 및 올살라진(Dipentum)과 같은 코르티코스테로이드 및 아미노살리실산염을 추가로 포함하는 항염증제가 포함됩니다.< /p>

시장 범위

“글로벌 염증 2028년 장질환 치료 시장 분석'

은 글로벌 시장 동향 분석에 특별히 초점을 맞춘 의료기기 산업에 대한 전문적이고 심층적인 연구입니다. 이 보고서는 약물 종류, 질병 적응증, 유통 채널 및 지역에 따른 상세한 시장 세분화를 통해 염증성 장 질환 치료 시장에 대한 개요를 제공하는 것을 목표로 합니다. 이 보고서는 주요 염증성 장 질환 치료 시장 플레이어의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.

시장 세분화

  • 약품 종류에 따라 시장은 아미노살리실산염, 면역조절제, TNF 억제제, 코르티코스테로이드로 분류됩니다.
  • 질병 적응증에 따라 시장은 크론병과 궤양성 대장염으로 구분됩니다
  • 유통 채널을 기준으로 전 세계 염증성 장질환 치료 시장은 병원 약국, 온라인 약국, 소매 약국으로 분류됩니다.
< p 스타일="줄 높이: 150%; 여백: 0in 0in 8pt; 글꼴 크기: 11pt; 글꼴 계열: Calibri, sans-serif;">

시장 역학

드라이버:

  • 염증성 장질환(IBD) 치료를 위한 강력한 파이프라인 제품의 존재
  • 크론병 및 궤양성 대장염의 유병률 증가

제한 사항:

  • 치료 비용이 높음

지역 프레임워크

이 보고서는 질적 및 양적 정보를 모두 포함하여 업계에 대한 자세한 개요를 제공합니다. 다양한 부문을 기반으로 글로벌 시장에 대한 개요 및 예측을 제공합니다. 또한 시장 규모도 제공합니다. 염증성 장질환 치료제 시장은 북미, 유럽, 아시아태평양(APAC), 중동 및 아프리카(MEA), 남미 등 5대 지역을 대상으로 2019년부터 2028년까지의 전망을 제시했다. 각 지역은 나중에 각 국가 및 분야별로 세분화됩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 해당 지역에 만연한 현재 추세 및 기회를 다루고 있습니다.

이 보고서는 수요와 공급 측면 모두에서 시장에 영향을 미치는 요인을 분석하고 예측 기간 동안 시장에 영향을 미치는 시장 역학, 즉 동인, 제한 사항, 기회 및 미래 추세를 추가로 평가합니다. 또한 이 보고서는 해당 지역의 염증성 장 질환 치료 시장에 영향을 미치는 정치적, 경제적, 사회적, 기술적 요인을 평가한 후 북미, 유럽, APAC, MEA 및 남미 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다.

COVID-19가 염증성 장 질환 치료 시장에 미치는 영향

COVID-19는 2019년 12월 중국 우한에서 처음 발생한 이후 빠른 속도로 전 세계로 확산되었습니다. 미국, 인도, 브라질, 러시아, 프랑스, 영국, 터키, 이탈리아, 스페인 등은 확진자 수와 사망자 수 측면에서 가장 큰 피해를 입은 국가들입니다. 전 세계적으로 치료를 받고 있습니다.

코로나19 상황으로 인해 질병을 예방/치료하기 위한 효과적인 백신, 생물학적 제제, 의약품 개발에 주력하는 기업이 많았습니다. 공급망 중단과 결합된 기타 의약품 또는 생물학적 제제의 개발 및 제조 둔화로 인해 시장은 2020년에 어려움을 겪었습니다. 또한, 봉쇄 조치의 여러 제한으로 인해 IBD 아동에 대한 관리는 최소한의 기준으로 유지되었습니다. 긴급 상황과 생물학적 제제 주입에 우선순위를 두고 원격 의료 서비스를 구현합니다.

시장 참여자

이 보고서는 유기 및 무기 성장 전략으로서 염증성 장 질환 치료 시장의 주요 발전 사항을 다루고 있습니다. 다양한 회사가 제품 출시, 제품 승인 등과 같은 유기적 성장 전략에 집중하고 있습니다. 특허, 이벤트 등 시장에서 목격된 무기 성장 전략 활동은 인수, 파트너십 및 협업으로, 이러한 활동을 통해 시장 참여자의 비즈니스 및 고객 기반 확장이 가능해졌습니다.염증성 장 질환 치료 시장의 시장 지불자는 예상됩니다. 글로벌 시장에서 염증성 장질환 치료에 대한 수요가 증가함에 따라 향후 수익성 있는 성장 기회를 모색하고 있습니다.

이 보고서에는 염증성 장 질환 치료 시장의 SWOT 분석 및 시장 전략과 함께 주요 기업의 프로필도 포함되어 있습니다. 또한 이 보고서는 다음과 같은 주요 업계 선수에 중점을 둡니다. 회사 프로필, 구성 요소, 제공 서비스 등의 정보, 지난 3년간의 재무 정보, 지난 5년간의 주요 발전 사항.

  • 화이자 주식회사
  • Novartis AG
  • JOHNSON 및 JOHNSON(Janssen Global Services, LLC)
  • AbbVie Inc.
  • 다케다 제약회사
  • ALLERGAN
  • CELGENE CORPORATION
  • Bausch Health
  • UCB, Inc.
  • Cosmo Pharmaceuticals NV

The Insight Partner의 전담 연구 및 분석 팀은 고급 통계 전문 지식을 갖춘 숙련된 전문가로 구성되어 있으며 기존 연구에서 다양한 사용자 정의 옵션을 제공합니다.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is inflammatory bowel disease?

Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

What factors drive the Inflammatory Bowel Disease Treatment Market?

The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

Who are the major players in the Inflammatory Bowel Disease Treatment Market?

The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

The List of Companies - Inflammatory Bowel Disease Treatment Market

  1. AbbVie Inc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc
  4. Biogen
  5. Novartis AG
  6. Lilly
  7. UCB S.A.
  8. CELLTRION INC.
  9. Merck & Co., Inc.
  10. Johnson & Johnson Services, Inc.
  11. Mindray Medical International Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports